TFRC and Alzheimer disease: Notably, since the expression levels of the transferrin receptor (TfR) along with the TfR-dependent internalization mechanisms are still preserved and not affected in brain capillary endothelial cells of both mouse models of AD and human patients, TfR particularly represents an appealing target for NP-mediated drug delivery strategies (Bourassa et al., 2019).